J9011 Datopotamab deruxtecan, 1 milligrams
Also known as: Dato-DXd, Datopotamab deruxtecan
Datopotamab deruxtecan administered by injection at 1 milligram per dose; an antibody-drug conjugate targeting tissue factor pathway inhibitor.
In Plain Language
Targeted cancer therapy injection; Antibody chemotherapy
Clinical Context
Used for HER2-low breast cancer and other solid tumors. Antibody-drug conjugate delivering chemotherapy directly to cancer cells.
RVU Information
CPT J9011 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9011?
CPT J9011 (Datopotamab deruxtecan, 1 milligrams) is a J Codes (Drugs) code. Datopotamab deruxtecan administered by injection at 1 milligram per dose; an antibody-drug conjugate targeting tissue factor pathway inhibitor.
How is J9011 administered?
CPT J9011 is administered by a healthcare provider, typically via injection or infusion. Used for HER2-low breast cancer and other solid tumors. Antibody-drug conjugate delivering chemotherapy directly to cancer cells. It is used by Oncology, Breast Cancer, Internal Medicine.
When is CPT J9011 used?
Used for HER2-low breast cancer and other solid tumors. Antibody-drug conjugate delivering chemotherapy directly to cancer cells.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.